A method of treating the mental state of subjects with significant neurological, functional and/or motor impairment from an ischemic stroke. The method comprises a step of intravenously dosing ischemic tolerant allogeneic mesenchymal bone marrow cells itMSCs to subjects with ischemic stroke.
